scispace - formally typeset
M

Maria Victoria Mogollón-Jimenez

Publications -  6
Citations -  190

Maria Victoria Mogollón-Jimenez is an academic researcher. The author has contributed to research in topics: Dilated cardiomyopathy & Internal medicine. The author has an hindex of 2, co-authored 3 publications receiving 90 citations.

Papers
More filters
Journal ArticleDOI

Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations

Fernando Dominguez, +31 more
- 13 Nov 2018 - 
TL;DR: DCM caused by mutations in BAG3 is characterized by high penetrance in carriers >40 years of age and a high risk of progressive heart failure.
Journal ArticleDOI

Formin Homology 2 Domain Containing 3 (FHOD3) Is a Genetic Basis for Hypertrophic Cardiomyopathy.

Juan Pablo Ochoa, +49 more
- 13 Nov 2018 - 
TL;DR: FHOD3 is a novel disease gene in hypertrophic cardiomyopathy, accounting for approximately 1% to 2% of cases, and the phenotype and the rate of cardiovascular events are similar to those reported in unselected cohorts.
Journal ArticleDOI

Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy

Luis Escobar-Lopez, +37 more
- 26 Oct 2021 - 
TL;DR: In this paper, the prognostic impact of genetic variants in nonischemic dilated cardiomyopathy (DCM) was assessed using disease-causality risk scores.
Journal ArticleDOI

Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy.

Luis Escobar-Lopez, +35 more
- 01 Sep 2022 - 
TL;DR: The Madrid Genotype Score as mentioned in this paper is a score that predicts the probability for positive genetic test result (G+) in patients with nonischemic dilated cardiomyopathy (DCM) or isolated left ventricular systolic dysfunction (LVSD).
Journal ArticleDOI

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy

Jesus G Mirelis, +27 more
- 29 Apr 2022 - 
TL;DR: This work investigated the combined influence of genotype and late gadolinium enhancement (LGE) in assessing prognosis in a large cohort of patients with DCM.